[1]
Karabin, T. et al. 2022. The recent guidelines for pharmacotherapy of Parkinson’s Disease. Current Issues in Pharmacy and Medical Sciences. 35, 2 (Aug. 2022), 80–85. DOI:https://doi.org/10.2478/cipms-2022-0015.